Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 60 out of 100. Getting a diagnosis

Topic: Risk, prevention and care in population studies

Plain-language summary

Results A total of 1808 dyads completed baseline assessments. Overall, 62 patients (5.1%) screened positive for cognitive impairment. There were no significant differences between the combined screening groups and no-screening group in SF-36 physical (24-month predicted difference, -0.21; 95% CI, -1.26-0.85) or mental (24-month predicted difference, 0.58; 95% CI, -0.18-1.33) component scores. Discussion This randomized clinical trial found that ADRD screening in PC was not associated with improvement in family member health-related quality of life, caregiver preparedness, or caregiving self-efficacy. Screening was also not associated with increased family member depression or anxiety. Low rates of positive screening and high rates of refusal for follow-up diagnostic assessment may help explain these findings.

What this study adds

Evidence grade: Null result

The record lists 1,808 participants. This trial found that dementia screening in primary care did not improve family members' health-related quality of life, caregiver preparedness, or caregiving self-efficacy. Reported effect size: 24-month SF-36 mental component difference 0.58 (95% CI -0.18 to 1.33), not significant.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Fowler, N. R., Perkins, A. J., Gao, S., Bakas, T., Head, K. J., Higbie, A., et al. (2026). Benefits and Harms of Dementia Screening for Family Members of Older Adults: A Randomized Clinical Trial. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2026.0844

Vancouver

Fowler NR, Perkins AJ, Gao S, Bakas T, Head KJ, Higbie A, et al. Benefits and Harms of Dementia Screening for Family Members of Older Adults: A Randomized Clinical Trial. JAMA Internal Medicine. 2026. doi:10.1001/jamainternmed.2026.0844. PMID: 42008257.

BibTeX

@article{fowler2026-42008257,
  author  = {Fowler, N. R. and Perkins, A. J. and Gao, S. and Bakas, T. and Head, K. J. and Higbie, A. and Baucco, C. and Callahan, C. M. and Williams-Farrelly, M. M. and Boustani, M. A.},
  title   = {{Benefits and Harms of Dementia Screening for Family Members of Older Adults: A Randomized Clinical Trial}},
  journal = {JAMA Internal Medicine},
  year    = {2026},
  doi     = {10.1001/jamainternmed.2026.0844},
  pmid    = {42008257},
  url     = {https://doi.org/10.1001/jamainternmed.2026.0844}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 10 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This trial found that dementia screening in primary care did not improve family members' health-related quality of life, caregiver preparedness, or caregiving self-efficacy. Screening also did not increase family member depression or anxiety.

Study details

Limitations

Low positive-screen rate and high refusal of follow-up limit power to detect effects of an actual diagnosis; screening tools were brief (Mini-Cog, MIS-T); single US health system region.

How this study scored 60/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 3 of 4; Study design 11 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 3 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 1 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 59 of the 98 points it could be judged on, which is 60 of 100. Total 60 of 100.59 of the 98 points we could judge = 60 of 100

Published in a leading specialty journal, and it is a randomized controlled trial. We have no data on free to read, so that was left out: it earned 59 of the 98 points we could judge it on, which is 60 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (JAMA Internal Medicine)
Journal's citation record 3 / 4 JAMA Internal Medicine: journal h-index 258 (OpenAlex, 2026-10-29)
Study design 11 / 12 A randomized controlled trial
Strength of evidence 3 / 5 Rated “null-result” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 3 / 4 1,808 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 1 / 2 Randomized (as stated in the record)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Malaz A. Boustani: h-index 65 (OpenAlex, whole career)
Institution's track record 1 / 3 Indiana University: institution h-index 926 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 8 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42008257)
Free to read — / 2 Access not recorded — left out of this score
Points 59 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 59 of the 98 points we could judge it on is 60 out of 100.
Total 60 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — Unpaywall lists this copy as free to read: the link above (checked 10 Oct 2026).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 18.

Related studies in Getting a diagnosis from nearby years

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →